Accelerated muscle and adipose tissue loss may predict survival in pancreatic cancer patients: the relationship with diabetes and anaemia

British Journal of Nutrition

Volumn 109, Issue 2, 2013, Pages 302-312

  Di Sebastiano, Katie M ^a   Yang, Lin ^b   Zbuk, Kevin ^b   Wong, Raimond K ^b   Chow, Tom ^b   Koff, David ^b   Moran, Gerald R ^c   Mourtzakis, Marina ^a  

^a UNIVERSITY OF WATERLOO   (Canada)

^b MCMASTER UNIVERSITY   (Canada)

^c LAWSON HEALTH RESEARCH INSTITUTE   (Canada)

Author keywords

Body composition; Cachexia; Muscle wasting; Weight loss

Indexed keywords

ADULT; AGED; ANEMIA; ARTICLE; BODY COMPOSITION; CACHEXIA; CANCER PROGNOSIS; CANCER SURVIVAL; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; DIABETES MELLITUS; FEMALE; HUMAN; INTRAABDOMINAL FAT; MALE; MUSCLE ATROPHY; PANCREAS CANCER; RISK FACTOR; SKELETAL MUSCLE; WEIGHT REDUCTION; ADIPOSE TISSUE; CONTROLLED STUDY; DISEASE ACTIVITY; DISEASE ASSOCIATION; MAJOR CLINICAL STUDY; PREDICTION;

AGED; AGED, 80 AND OVER; ANEMIA; BODY COMPOSITION; CACHEXIA; DIABETES COMPLICATIONS; EARLY DIAGNOSIS; FEMALE; HUMANS; INTRA-ABDOMINAL FAT; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; MUSCLE, SKELETAL; NEOPLASM STAGING; PANCREATIC NEOPLASMS; SARCOPENIA; SEVERITY OF ILLNESS INDEX; SURVIVAL ANALYSIS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84873025841     PISSN: 00071145     EISSN: 14752662     Source Type: Journal    
DOI: 10.1017/S0007114512001067     Document Type: Article

References (40)

1. Vigano M, Bruera E, Jhangri GS, et al.(2000) Clinical survival predictors in patients with advanced cancer. Arch Intern Med 160, 861-868
2. Bachmann J, Heiligensetzer M, Krakowski-Roosen H, et al.(2008) Cachexia worsens prognosis in patients with resectable pancreatic cancer. J Gastrointest Surg 12, 1193-1201
3. Fearon K, Strasser F, Anker SD, et al.(2011) Definition and classification of cancer cachexia: And international consensus. Lancet Oncol 12, 489-495
4. Wigmore SJ, Plester CE, Richardson RA, et al.(1997) Changes in nutritional status associated with unresectable pancreatic cancer. Br J Cancer 75, 106-109
5. Wang X, Hu Z, Hu J, et al.(2006) Insulin resistance accelerates muscle protein degradation: Activation of the ubiquitin- proteasome pathway by defects in muscle cell signaling. Endocrinology 147, 4160-4168
6. Evans WJ, Morely JE, Argiles J, et al.(2008) Cachexia: A new definition. Clin Nutr 27, 793-799
7. Liedman B, Andersson H, Bosaeus I, et al.(1997 Changes in body composition after gastrectomy: Results of a controlled, prospective clinical trial. World J Surg 21, 416-421
8. Tan BHL, Birdsell LA, Martin L, et al.(2009) Sarcopenia in overweight or obese patients is an adverse prognostic factor in pancreatic cancer. Clin Cancer Res 15, 6973-6973
9. Despres JP & Lemieux I (2006) Abdominal obesity and metabolic syndrome. Nature 444, 881-887
10. Johansen D, Stocks T, Jonsson H, et al.(2010) Metabolic factors and the risk of pancreatic cancer: A prospective analysis of almost 580,000 men and women in the metabolic syndrome and cancer project. Cancer Epidemiol Biomarkers Prev 19, 2307-2317
11. Balentine CJ, Enriquez J, Fisher W, et al.(2010 Intra-abdominal fat predicts survival in pancreatic cancer. J Gastrointest Surg 14, 1832-1837
12. World Health Organization (2001) Iron Deficiency Anaemia: Assessment, Prevention, and Control. Geneva: World Health Organization. http://whqlibdoc. who.int/hq/2001/WHO-NHD- .3.pdf (WHO/NHD/0.1.3
13. Shen W, Punyanitya M, Wang Z, et al.(2004) Total body skeletal muscle and adipose tissue volumes; estimates form a single abdominal cross-sectional image. J Appl Physiol 97, 2333-2338
14. Shen W, Punyanitya M, Wang Z, et al.(2004) Visceral adipose tissue relations between single-slice areas and total volume. Am J Clin Nutr 80, 271-278
15. Mourtzakis M, Prado CMM, Lieffers JR, et al.(2008 A practical and precise approach to quantifications of body composition in cancer patients using computed tomography images acquired during routine care. Appl Physiol Nutr Metab 33, 997-1006
16. Alberti G, Zimmet P, Shaw J, et al.(2006) The IDF consensus worldwide definition of the metabolic syndrome. International Diabetes Federation. http://www.idf.org/ webdata/docs/IDF-Meta-def-final.pdf
17. Mitsiopoulos N, Baumgartner RN, Heymsfield SB, et al.(1998) Cadaver validation of skeletal muscle measurement by magnetic resonance imaging and computerized tomography. J Appl Physiol 85, 115-122
18. Miller KD, Jones E, Yanovski JA, et al.(1998) Visceral abdominal-fat accumulation associated with use of indinavir. Lancet 351, 871-875
19. Snyder WS, Cooke MJ, Manssett ES, et al.(1975) Report of the Task Group on Reference Man. Oxford: Pergamon
20. World Health Organization (2001) Obesity: Preventing and Managing the Global Epidemic. WHO Technical Report Series no. 894. Geneva: WHO
21. Frontera WR, Hughes VA, Fielding RA, et al.(2000) Aging of skeletal muscle; a 12-year longitudinal study. J Appl Physiol 88, 1321-1326
22. Lexell J, Taylor CC & Sjostrom M (1988) What is the cause of the aging atrophy? Total number, size, and proportion of different fibre types in whole vastus lateralis from 15- to 83-year-old men. J Neurol Sci 84, 275-294
23. Lieffers JR, Mourtzakis M, Hall KD, et al.(2009) A viscerally driven cachexia syndrome in patients with advanced colorectal cancer; contributions of organ and tumor mass to whole-body energy demands. Am J Clin Nutr 89, 1173-1179
24. Hallgreen CE & Hall KD (2008) Allometric relationship between changes of visceral fat and total mass. Int J Obes (Lond) 32, 845-852
25. Bruckart K, Beca S, Urban RJ, et al.(2010) Pathogenesis of muscle wasting in cancer cachexia: Targeted anabolic and anti-catabolic therapies. Curr Opin Clin Nutr Metab Care 13, 410-416
26. Glass DJ (2010) Signaling pathways perturbing muscle mass. Curr Opin Clin Nutr Metab Care 13, 225-229
27. Tayek JA (1992) A review of cancer cachexia and abnormal glucose metabolism. J Am Coll Nutr 11, 445-456
28. Park SW, Goodpaster BH, Lee JS, et al.(2009) Health, aging, and body composition study. Excessive loss of skeletal muscle mass in older adults with type 2 diabetes. Diabetes Care 32, 1993-1997
29. Kim TN, Park MS, Yang SJ, et al.(2010) Prevalence and determinant factors of sarcopenia in patients with type 2 diabetes: The Korean Sarcopenic Obesity Study (KSOS Diabetes Care 33, 1497-1499
30. Kahl J, Wykes SM, Russell ST, et al.(2005) Expression of the ubiquitin-proteasome pathway and muscle loss in experimental cancer cachexia. Br J Cancer 93, 774-780
31. Weiss G & Goodnough LT (2005) Anemia of chronic disease. N Engl J Med 352, 1011-1023
32. Rasic-Milutinovic Z, Perunicic-Pekovic G, Ristic-Medic D, et al.(2009) Insulin resistance and chronic inflammation are associated with muscle wasting in end-stage renal disease patients on hemodialysis. Gen Physiol Biophys 28, 184-189 (Spec No
33. Morley JE (2009) Calories and cachexia. Curr Opin Clin Nutr Metab Care 12, 607-610
34. Colomer R, Moreno-Nogueira JM, Garcia-Luna PP, et al.(2007) n-3 Fatty acids, cancer and cachexia: A systematic review of the literature. Br J Nutr 97, 823-831
35. Brown TT, Zelnik DL & Dobs AS (2003) Fish oil supplementation in the treatment of cachexia in pancreatic cancer patients. Int J Gastrointest Cancer 34, 143-150
36. Mantovani G, Maccio A, Madeddu C, et al.(2010) Randomized phase III clinical trial of five different arms of treatment in 332 patients with cancer cachexia. Oncologist 15, 200-211
37. Holly EA, Chaliha I, Bracci PM, et al.(2004) Signs and symptoms of pancreatic cancer: A population-based case-control study in the San Francisco Bay area. Clin Gastroenterol Hepatol 2, 510-517
38. Wasif N, Ko CY, Farrell J, et al.(2010) Impact of tumor grade on prognosis in pancreatic cancer: Should we include grade in AJCC staging? Ann Surg Oncol 17, 2312-2320
39. Kiyama T, Mizutani T, Okuda T, et al.(2005) Postoperative changes in body composition after gastrectomy. J Gastrointest Surg 9, 313-319
40. Awad S, Tan BH, Cui H, et al.(2011) Marked changes in body composition following neoadjuvant chemotherapy for oesophagogastric cancer. Clin Nutr 31, 74-77.